These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 36614848)

  • 1. Advanced Hemodynamic Monitoring Allows Recognition of Early Response Patterns to Diuresis in Congestive Heart Failure Patients.
    Dagan M; Kolben Y; Goldstein N; Ben Ishay A; Fons M; Merin R; Eisenkraft A; Amir O; Asleh R; Ben-Yehuda A; Nachman D
    J Clin Med; 2022 Dec; 12(1):. PubMed ID: 36614848
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diurnal cardio-respiratory changes in ambulatory individuals deciphered using a multi-parameter wearable device.
    Nachman D; Eisenkraft A; Kolben Y; Carmon E; Hazan E; Goldstein N; Ben Ishay A; Hershkovitz M; Fons M; Merin R; Amir O; Asleh R; Gepner Y
    Digit Health; 2023; 9():20552076231218885. PubMed ID: 38053733
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of Early Assesment of Diuresis and Natriuresis in Detecting In-Hospital Diuretic Resistance in Acute Heart Failure.
    García-Magallón B; Cobo-Marcos M; Martiarena AD; Hernández EM; Martín Jiménez ML; García AM; De Castro Campos D; Martín PV; Terciado FH; González RG; Matutano Muñoz A; Escribano García D; Domínguez F; Sainz Herrero A; Gómez Peñalba C; Garcia-Pavia P; Segovia J
    Front Physiol; 2022; 13():887734. PubMed ID: 35586715
    [No Abstract]   [Full Text] [Related]  

  • 4. Effects of nesiritide and predictors of urine output in acute decompensated heart failure: results from ASCEND-HF (acute study of clinical effectiveness of nesiritide and decompensated heart failure).
    Gottlieb SS; Stebbins A; Voors AA; Hasselblad V; Ezekowitz JA; Califf RM; O'Connor CM; Starling RC; Hernandez AF
    J Am Coll Cardiol; 2013 Sep; 62(13):1177-83. PubMed ID: 23747790
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Renal negative pressure treatment as a novel therapy for heart failure-induced renal dysfunction.
    Rao VS; Maulion C; Asher JL; Ivey-Miranda JB; Cox ZL; Moreno-Villagomez J; Mahoney D; Turner JM; Wilson FP; Wilcox CS; Testani JM
    Am J Physiol Regul Integr Comp Physiol; 2021 Oct; 321(4):R588-R594. PubMed ID: 34405731
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pulse contour cardiac output monitoring in acute heart failure patients : Assessment of hemodynamic measurements.
    Wernly B; Lichtenauer M; Franz M; Fritzenwanger M; Kabisch B; Figulla HR; Jung C
    Wien Klin Wochenschr; 2016 Dec; 128(23-24):864-869. PubMed ID: 27525745
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypertonic-hyperoncotic solutions improve cardiac function in children after open-heart surgery.
    Schroth M; Plank C; Meissner U; Eberle KP; Weyand M; Cesnjevar R; Dötsch J; Rascher W
    Pediatrics; 2006 Jul; 118(1):e76-84. PubMed ID: 16751617
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predicted Cardiac Hemodynamic Consequences of the Renal Actions of SGLT2i in the DAPA-HF Study Population: A Mathematical Modeling Analysis.
    Yu H; Tang W; Greasley PJ; Penland RC; Boulton DW; Hallow KM
    J Clin Pharmacol; 2021 May; 61(5):636-648. PubMed ID: 33091173
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The dobutamine-dopamine combination versus amrinone in congestive heart failure with a marked edematogenic sign complicated by functional kidney failure. A comparison between 2 different models of inotropic stimulation and diuresis potentiation].
    De Vecchis R; Pucciarelli G; Nocerino L; Cocozza M; Setaro A; Torre G; Imperatore F
    Minerva Cardioangiol; 1998 May; 46(5):163-74. PubMed ID: 9842199
    [TBL] [Abstract][Full Text] [Related]  

  • 10. GLP-1 mediated diuresis and natriuresis are blunted in heart failure and restored by selective afferent renal denervation.
    Katsurada K; Nandi SS; Zheng H; Liu X; Sharma NM; Patel KP
    Cardiovasc Diabetol; 2020 May; 19(1):57. PubMed ID: 32384887
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Responsiveness of Noninvasive Continuous Cardiac Output Monitoring During the Valsalva Maneuver.
    Delaney LJ; Bellomo R; van Haren F
    Clin Nurs Res; 2020 Feb; 29(2):127-132. PubMed ID: 29514518
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hyperoxygenation in pregnancy exerts a more profound effect on cardiovascular hemodynamics than is observed in the nonpregnant state.
    McHugh A; El-Khuffash A; Bussmann N; Doherty A; Franklin O; Breathnach F
    Am J Obstet Gynecol; 2019 Apr; 220(4):397.e1-397.e8. PubMed ID: 30849354
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Continuous Wearable Monitoring Analytics Predict Heart Failure Hospitalization: The LINK-HF Multicenter Study.
    Stehlik J; Schmalfuss C; Bozkurt B; Nativi-Nicolau J; Wohlfahrt P; Wegerich S; Rose K; Ray R; Schofield R; Deswal A; Sekaric J; Anand S; Richards D; Hanson H; Pipke M; Pham M
    Circ Heart Fail; 2020 Mar; 13(3):e006513. PubMed ID: 32093506
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Remote monitoring: Doomed to let down or an attractive promise?
    Lucà F; Cipolletta L; Di Fusco SA; Iorio A; Pozzi A; Rao CM; Ingianni N; Benvenuto M; Madeo A; Fiscella D; Benedetto D; Francese GM; Gelsomino S; Zecchin M; Gabrielli D; Gulizia MM
    Int J Cardiol Heart Vasc; 2019 Sep; 24():100380. PubMed ID: 31193998
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Time of peak nocturnal diuresis rate between men with secondary nocturnal polyuria versus nocturnal polyuria syndrome.
    Monaghan TF; Epstein MR; Bliwise DL; Michelson KP; Wu ZD; Lazar JM; Everaert K; Kabarriti AE; Holmes A; Wein AJ; Weiss JP
    Neurourol Urodyn; 2020 Feb; 39(2):785-792. PubMed ID: 31961968
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Wearable and Noninvasive Device for Integral Congestive Heart Failure Management in the IoMT Paradigm.
    Ausín JL; Ramos J; Lorido A; Molina P; Duque-Carrillo JF
    Sensors (Basel); 2023 Aug; 23(16):. PubMed ID: 37631594
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Hemodynamic changes produced by intravenous bumetanide in congestive heart failure].
    Ziacchi V; Rossi A; Lomanto B
    G Ital Cardiol; 1981; 11(1):104-9. PubMed ID: 7239091
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Hemodynamic and clinical effects and treatment tolerance with low-dose iv amrinone in patients with refractory heart failure: a multicenter study. The Group for Research on Amrinone in the Treatment of Refractory Heart Failure].
    Dei Cas L; Metra M; Nodari S; Raddino R; Visioli O
    Cardiologia; 1991 May; 36(5):363-71. PubMed ID: 1756541
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of cardiac function on the diuretic and hemodynamic effects of the loop diuretic piretanide.
    Hasenfuss G; Holubarsch C; Herzog C; Knauf H; Spahn H; Mutschler E; Just H
    Clin Cardiol; 1987 Feb; 10(2):83-8. PubMed ID: 3815928
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.